Benzoyl-piperidine derivatives as 5HT2/ D3 modulators

Details for Australian Patent Application No. 2007216563 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Luebbers, Thomas; Jaeschke, Georg; Rodriguez Sarmiento, Rosa Maria; Roche, Olivier; Gobbi, Luca; Steward, Lucinda

Agent Spruson & Ferguson

Pub. Number AU-B-2007216563

PCT Pub. Number WO2007/093540

Priority 06110112.7 17.02.06 EP; 06112464.0 11.04.06 EP

Filing date 7 February 2007

Wipo publication date 23 August 2007

Acceptance publication date 9 August 2012

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 31/505 - Pyrimidines

A61P 25/18 Drugs for disorders of the nervous system

C07C 211/32 Compounds containing amino groups bound to a carbon skeleton

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/093540 Priority application(s): WO2007/093540

9 August 2012 Application Accepted

  Published as AU-B-2007216563

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216564-Heterocyclic antiviral compounds

2007216558-A method of using a micronutrient as safener for a triazole for controlling harmful fungi